Eden Research plc (EDEN.L)
- Previous Close
3.8000 - Open
3.8000 - Bid --
- Ask --
- Day's Range
3.8000 - 4.0000 - 52 Week Range
2.2330 - 4.8000 - Volume
98,482 - Avg. Volume
459,608 - Market Cap (intraday)
20.267M - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date May 6, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
20.00
Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products comprising companion animal, bio-control, parasite treatments, and insect sprays. Eden Research plc was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.
www.edenresearch.com23
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EDEN.L
View MorePerformance Overview: EDEN.L
Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EDEN.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EDEN.L
View MoreValuation Measures
Market Cap
20.27M
Enterprise Value
16.76M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.71
Price/Book (mrq)
1.72
Enterprise Value/Revenue
3.90
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-44.31%
Return on Assets (ttm)
-8.54%
Return on Equity (ttm)
-15.07%
Revenue (ttm)
4.3M
Net Income Avi to Common (ttm)
-1.91M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
3.67M
Total Debt/Equity (mrq)
1.42%
Levered Free Cash Flow (ttm)
-3.07M